Atorvastatin & Clopidogrel Tablets – Otovas C Tablets

OTOVAS C Tablets – Dual Protection for Cholesterol Control & Clot Prevention.

OTOVAS C Tablets – The dual combination of Atorvastatin & Clopidogrel Tablets provides a comprehensive approach to cardiovascular protection:
Atorvastatin – An HMG-CoA reductase inhibitor (statin) that lowers LDL cholesterol and triglycerides while increasing HDL cholesterol, helping to reduce the risk of atherosclerosis.
Clopidogrel – An antiplatelet agent that prevents blood clots by inhibiting platelet aggregation, reducing the chances of stroke and heart attack.

Key Benefits of Atorvastatin & Clopidogrel Tablets – OTOVAS C Tablets
✅ Dual Benefits for Heart Protection – Provides both cholesterol reduction and clot prevention, lowering the risk of heart attacks, strokes, and complications in high-risk patients.
✅ Broad Cardiovascular Risk Management – Atorvastatin reduces cholesterol and slows atherosclerosis progression, while Clopidogrel prevents clot formation in narrowed arteries for comprehensive protection.
✅ Proven Efficacy in High-Risk Groups – Clinical evidence supports significant reduction of major cardiovascular events in patients with heart disease or risk factors such as diabetes, hypertension, or smoking.

Recommended By Specialists:
👨‍⚕️ Cardiologists: For patients with coronary artery disease, post–heart attack (MI), stent placement, or stroke prevention.
👨‍⚕️ General Physicians: For high-risk patients requiring cholesterol control and clot prevention.
👨‍⚕️ Neurologists: For secondary prevention of ischemic stroke or transient ischemic attack (TIA).

INDICATIONS:
✅ Prevention of Cardiovascular Diseases
✅ Post-Revascularization Therapy
✅ Prevent Progression of Atherosclerosis